Katy Hamana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katy Hamana has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Lori Quinn
Neurorehabilitation Research Laboratory, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, NY
6 shared publications - Monica Busse
Centre for Trials Research, School of Medicine, Cardiff University
6 shared publications - Anne Elizabeth Rosser
Brain Repair Group, Cardiff University, Cardiff, UK
4 shared publications - Mark Kelson
University of Exeter
3 shared publications Beth Ann Griffin
RAND Corporation, Arlington, VA, USA
2 shared publications- Cheney Drew
Centre for Trials Research, Cardiff University, Cardiff, UK
2 shared publications
Latest Publications
- Open Access
- 28 June 2022
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 101, 75-89
Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease
- 28 June 2022
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 101, 75-89
Open AccessPhysical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease
- 22 May 2021
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 43 (11) , 1565-1575
An exploration of physical activity experiences throughout the Huntington?s disease journey: supporting development of theoretically underpinned complex interventions
Purpose: Huntington?s disease is an autosomal dominant neurodegenerative disease. Progressive physical, behavioural and cognitive impairments cause loss of independent function. Physical activity interventions are important components of comprehensive intervention strategies and may help alter the functional decline trajectory. Qualitative research has an important role to play in developing theoretically sound, well-defined physical activity interventions in Huntington?s disease. Materials and methods: Eight focus groups were conducted with people with prodromal to late stage Huntington?s disease, caregivers (family members/formal), and healthcare professionals. An analytical coding framework was developed from the data and Levanthal?s self-regulation model to assist analysis. Results and conclusions: Key themes were identified: evolving representations of Huntington?s disease and physical activity; varying social environment of the person with Huntington?s disease and the impact on physical activity; achieving physical activity participation while coping with the nuances of Huntington?s disease. Levanthal?s model facilitated understanding of physical activity experiences, however with progression, self-regulation of activities needs to become more collaborative with caregivers. A modified self-regulation model specific to physical activity in Huntington?s disease is presented. Using a novel approach to generate new understanding of physical activity across the Huntington?s disease lifespan facilitated development of an original and significant theoretical foundation to underpin development of a range of much needed physical activity and exercise interventions in Huntington?s disease.
- 22 May 2021
- Published by Taylor & Francis in Disability and Rehabilitation
- Vol. 43 (11) , 1565-1575
An exploration of physical activity experiences throughout the Huntington?s disease journey: supporting development of theoretically underpinned complex interventions
Purpose: Huntington?s disease is an autosomal dominant neurodegenerative disease. Progressive physical, behavioural and cognitive impairments cause loss of independent function. Physical activity interventions are important components of comprehensive intervention strategies and may help alter the functional decline trajectory. Qualitative research has an important role to play in developing theoretically sound, well-defined physical activity interventions in Huntington?s disease. Materials and methods: Eight focus groups were conducted with people with prodromal to late stage Huntington?s disease, caregivers (family members/formal), and healthcare professionals. An analytical coding framework was developed from the data and Levanthal?s self-regulation model to assist analysis. Results and conclusions: Key themes were identified: evolving representations of Huntington?s disease and physical activity; varying social environment of the person with Huntington?s disease and the impact on physical activity; achieving physical activity participation while coping with the nuances of Huntington?s disease. Levanthal?s model facilitated understanding of physical activity experiences, however with progression, self-regulation of activities needs to become more collaborative with caregivers. A modified self-regulation model specific to physical activity in Huntington?s disease is presented. Using a novel approach to generate new understanding of physical activity across the Huntington?s disease lifespan facilitated development of an original and significant theoretical foundation to underpin development of a range of much needed physical activity and exercise interventions in Huntington?s disease.
- 17 May 2019
- Published by Oxford University Press (OUP) in Physical Therapy
- Vol. 99 (9) , 1201-1210
Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease
Background: Exercise is emerging as an important aspect in the management of disease-related symptoms and functional decline in people with Huntington disease (HD). Long-term evaluation of physical activity and exercise participation in HD has yet to be undertaken. Objective: The objective is to investigate the feasibility of a nested randomized controlled trial (RCT) alongside a longitudinal observational study of physical activity and exercise outcomes in people with HD. Design: This will be a 12-month longitudinal observational study (n = 120) with a nested evaluation of a physical activity intervention (n = 30) compared with usual activity (n = 30) using a “trial within a cohort” design. Setting: The study will take place in HD specialist clinics in Germany, Spain, and the United States, with intervention delivery in community settings. Participants: The participants will have early-mid–stage HD and be participating in the Enroll-HD study. Intervention: This will be a 12-month physical activity behavioral change intervention, delivered by physical therapists in 18 sessions, targeting uptake of aerobic exercise and increased physical activity. Measurements: All participants (n = 120) will complete Enroll-HD assessments (motor, cognitive, behavioral, and quality of life) at baseline and at 12 months. Additional Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD) assessments include fitness (predicted maximal oxygen uptake [V o2max]), self-reported and quantitative measures of physical activity, disease-specific symptoms, and walking endurance. RCT participants (n = 60) will complete an additional battery of quantitative motor assessments and a 6-month interim assessment. Enroll-HD data will be linked to PACE-HD physical activity and fitness data. Limitations: The limitations include that the embedded RCT is open, and assessors at RCT sites are not blinded to participant allocation. Conclusion: PACE-HD will enable determination of the feasibility of long-term physical activity interventions in people with HD. The novel “trial within a cohort” design and incorporation of data linkage have potential to reduce participant burden. This design could be applied to other neurological diseases and movement disorders where recruitment and retention are challenging.
- 17 May 2019
- Published by Oxford University Press (OUP) in Physical Therapy
- Vol. 99 (9) , 1201-1210
Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease
Background: Exercise is emerging as an important aspect in the management of disease-related symptoms and functional decline in people with Huntington disease (HD). Long-term evaluation of physical activity and exercise participation in HD has yet to be undertaken. Objective: The objective is to investigate the feasibility of a nested randomized controlled trial (RCT) alongside a longitudinal observational study of physical activity and exercise outcomes in people with HD. Design: This will be a 12-month longitudinal observational study (n = 120) with a nested evaluation of a physical activity intervention (n = 30) compared with usual activity (n = 30) using a “trial within a cohort” design. Setting: The study will take place in HD specialist clinics in Germany, Spain, and the United States, with intervention delivery in community settings. Participants: The participants will have early-mid–stage HD and be participating in the Enroll-HD study. Intervention: This will be a 12-month physical activity behavioral change intervention, delivered by physical therapists in 18 sessions, targeting uptake of aerobic exercise and increased physical activity. Measurements: All participants (n = 120) will complete Enroll-HD assessments (motor, cognitive, behavioral, and quality of life) at baseline and at 12 months. Additional Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD) assessments include fitness (predicted maximal oxygen uptake [V o2max]), self-reported and quantitative measures of physical activity, disease-specific symptoms, and walking endurance. RCT participants (n = 60) will complete an additional battery of quantitative motor assessments and a 6-month interim assessment. Enroll-HD data will be linked to PACE-HD physical activity and fitness data. Limitations: The limitations include that the embedded RCT is open, and assessors at RCT sites are not blinded to participant allocation. Conclusion: PACE-HD will enable determination of the feasibility of long-term physical activity interventions in people with HD. The novel “trial within a cohort” design and incorporation of data linkage have potential to reduce participant burden. This design could be applied to other neurological diseases and movement disorders where recruitment and retention are challenging.
- Open Access
- 14 April 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 54, 56-61
Alterations in the metabolic and cardiorespiratory response to exercise in Huntington's Disease
- 14 April 2018
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 54, 56-61
Open AccessAlterations in the metabolic and cardiorespiratory response to exercise in Huntington's Disease
- Open Access
- 1 October 2016
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 31, 46-52
A randomized, controlled trial of a multi-modal exercise intervention in Huntington’s disease
- 1 October 2016
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 31, 46-52
Open AccessA randomized, controlled trial of a multi-modal exercise intervention in Huntington’s disease
- 1 September 2016
- Published by Elsevier in Gait & Posture
- Vol. 49, 283-289
Motor-cognitive dual-task deficits in individuals with early-mid stage Huntington disease
- 1 September 2016
- Published by Elsevier in Gait & Posture
- Vol. 49, 283-289
Motor-cognitive dual-task deficits in individuals with early-mid stage Huntington disease
- 21 January 2013
- Published by Springer Nature
Open AccessTask-related TRAINing in Huntingtons Disease